The global Plant-based Vaccines Market Growth Accelerated by Increasing Demand for Sustainable Vaccine Alternatives

 

Plant-based Vaccines Market

Plant-based vaccines offer convenient vaccination with high efficacy and safety. They utilize plant platforms to produce vaccine antigens that can trigger an immune response. Plant-based vaccines are manufactured using plant expression systems developed by fusing genes encoding vaccine antigens to plant viruses or plant cells. Once inside the plant, these genes instruct the plant to produce the vaccine antigen.

The global plant-based vaccines market is estimated to be valued at US$ 98.19 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Dynamics:

 

High Growth Owing to Increasing Prevalence of Chronic Diseases: Chronic diseases such as cancer, diabetes, and cardiovascular diseases have high prevalence worldwide. According to World Health Organization (WHO), chronic diseases accounted for approximately 60% of all global deaths in 2020. Plant-based vaccines offer safe and convenient options for chronic disease treatment and prevention. For example, plant-produced vaccines are being developed against human papillomavirus that causes cervical cancer. Increasing burden of chronic diseases is expected to drive high demand for plant-based vaccines over the forecast period.

 

Advantages of Plant Platform: Plant platforms offer significant advantages over traditional egg-based or animal cell-based vaccine manufacturing technologies. Plants allow for rapid, transient, and scalable production of vaccine antigens at low-cost. Plant-based vaccines also eliminate the risk of contamination from pathogens affecting animal health. Further, several plant species approved for vaccine production can grow in non-arable lands and do not require fertile agricultural areas. The versatile advantages of plant platforms are estimated to support market growth.

 

SWOT Analysis

 

Strength:Plant-based vaccines have several advantages over traditional vaccine production methods. They can be produced rapidly, at large-scale and low-cost compared to conventional methods. Plant cells do not harbor human pathogens, removing the risk of contamination. Production of plant-based vaccines is more environment-friendly and ecologically sustainable compared to reliance on animals.

 

Weakness: Plant-based vaccines production is still at an early commercialization stage. Regulatory approvals for human use take significant time and resources due to safety validation requirements. Storage and distribution of plant-based vaccines pose unique challenges due to their biological nature compared to traditional vaccines.

 

Opportunity: The COVID-19 pandemic has demonstrated the urgent global need for rapid and mass vaccine production capabilities. Plant-based vaccine platforms are highly suited to address future pandemics or bioterror attacks. Developing countries with limited healthcare infrastructure could benefit immensely from low-cost plant-based vaccines.

 

Threats: Established traditional vaccine makers may view plant-based vaccines as disruptive competition and try to delay or limit their adoption. Public perception and acceptance of entirely novel plant-derived vaccine modalities needs to be actively addressed. Dependence on agricultural infrastructure for vaccine supply also comes with produceability and supply chain reliability risks.

 

 

Key Takeaways

 

The Global Plant-Based Vaccines Market Size is expected to witness high growth over the forecast period of 2023 to 2030. Advancements in plant molecular farming and biomolecular pharming technologies are enabling development of affordable and scalable vaccines against several infectious diseases and cancer. The global plant-based vaccines market is estimated to be valued at US$ 98.19 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030.

Regions like North America and Europe currently dominate the market due to presence of major companies and higher R&D investments. However, Asian countries are emerging as high potential markets due to their large population base and growing biotech industry. The Asia Pacific region is poised to be the fastest growing market for plant-based vaccines owing to initiatives by governments in countries like India, China and Korea to establish indigenous vaccine production capabilities. India for example has implemented a USD 500 million program to build vaccine manufacturing infrastructure through public-private partnerships. This is expected to significantly boost regional market growth over the coming years.

 

Key players: Key players operating in the plant-based vaccines market are Medicago, Inc., IBIO, Inc., Icon Genetics GmbH, Lumen Bioscience, Inc., British American Tobacco Plc., Creative Biolabs, Inc., Leaf Expression Systems Ltd., ZYUS Life Sciences Inc., PlantForm Corporation, and Infectious Disease Research Institute (IDRI). These companies are engaged in developing plant-based vaccine candidates against various infectious and chronic diseases through advancements in molecular pharming and biomolecular farming technologies.


Get More Insights Here

 

https://careersplay.com/artificial-intelligence-in-genomics-unlocking-the-mysteries-of-human-dna

https://www.newswirestats.com/plant-based-vaccines-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

"Global Heparin Market: Current Trends and Future Prospects"

Image
  Heparin, a crucial anticoagulant, has been a mainstay in the pharmaceutical industry for many years. It plays a pivotal role in preventing and treating conditions such as deep vein thrombosis, pulmonary embolism, and various cardiovascular diseases. As we delve into the current state of the heparin market, we will explore the trends, challenges, and opportunities that shape this vital segment of the pharmaceutical industry. Market Overview: The global heparin market has experienced steady growth over the years, driven by an aging population, increasing cases of cardiovascular diseases, and a rising awareness of the importance of anticoagulants in healthcare. Heparin is available in various forms, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each with its own set of applications and market dynamics. Trends: 1.      Rising Demand for LMWH : Low molecular weight heparin is gaining popularity due to its ease of administr...
Read more

"Advancements in Cystic Fibrosis Treatment: A Comprehensive Market Analysis"

Image
  The cystic fibrosis market has seen significant advancements and changes in recent years. Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to thick and sticky mucus production that can cause serious respiratory and digestive complications. The introduction of new therapies and treatments, such as CFTR modulators, has revolutionized the management of cystic fibrosis, offering hope and improved quality of life for patients. These drugs target the underlying genetic mutations responsible for the condition, helping to alleviate symptoms and slow disease progression. However, challenges remain in the cystic fibrosis market . Access to these ground-breaking therapies can be limited due to high costs, and ongoing research is needed to develop treatments for all genetic mutations associated with the disease. Additionally, the market continues to evolve as new therapies and innovations emerge. Collaborative efforts between pharmaceutical compani...
Read more

Botanical Packaging is Estimated to Witness High Growth Owing to Growing Environmental Concerns

Image
  Botanical Packaging Market Botanical packaging involves using various plant-based materials like corn starch, wheat starch, soy protein, bamboo, bagasse as raw materials for manufacturing boxes, cartons, bags and wrapping films for packaging applications. These biodegradable materials offer attractive sustainability advantages over traditional petroleum-based plastics. Botanical packaging finds widespread application in food, beverage, pharmaceutical, personal care and homecare industries for primary, secondary and tertiary packaging needs. The global botanical packaging Market is estimated to be valued at US$ 138.24 Bn in 2023 and is expected to exhibit a CAGR of 34% over the forecast period 2024 to 2031.   Market Dynamics: Growing environmental concerns about the menace of plastic pollution have been fuelling adoption of sustainable packaging alternatives globally. One of the key drivers for botanical packaging market is the stringent government policies and regulati...
Read more